Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PRZ-ISMN DIN 02562561

Status: Marketed
Holder: PHARMARIS CANADA INC
Molecule: ISOSORBIDE-5-MONONITRATE

Health Canada record

Active ingredient(s)ISOSORBIDE-5-MONONITRATE 60 MG
Dosage formTablet (Extended-Release)
RouteOral
ScheduleETHICAL
ClassHuman
ATCC01DA14 ISOSORBIDE MONONITRATE
Original market date06-Aug-2026
Current status date06-Aug-2026
SourceHealth Canada DPD

Establishment licence of the holder

Pharmaris Canada Inc. — licence 3-002451, currently licensed, last inspection rating C (2023-01-19).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ISOSORBIDE-5-MONONITRATE

DINProductCompanyFormStrengthStatus
02272830APO-ISMNAPOTEX INCTablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGMarketed
02301288PMS-ISMNPHARMASCIENCE INCTablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGMarketed
02311321PRO-ISMN - 60PRO DOC LIMITEETablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGMarketed
02570742RIVA-ISMNLABORATOIRE RIVA INC.Tablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGApproved
02307758DOM-ISMNDOMINION PHARMACALTablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGCancelled Pre Market
02126559IMDURJUNO PHARMACEUTICALS CORP.Tablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGDormant
02446073ISMNSIVEM PHARMACEUTICALS ULCTablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGCancelled Post Market
02058472ISMO TAB 20MGWYETH-AYERST CANADA INC.TabletISOSORBIDE-5-MONONITRATE 20 MGCancelled Post Market
02307731PHL-ISMNPHARMEL INCTablet (Extended-Release)ISOSORBIDE-5-MONONITRATE 60 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
363032025-10-31Abbreviated New Drug Submission (ANDS)

International API supply for ISOSORBIDE-5-MONONITRATE

1 active FDA Drug Master Files.

Request a quote for PRZ-ISMN

How to read a Canadian DIN record